This company has been marked as potentially delisted and may not be actively trading. Symmetry Medical (SMA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsInsider TradesTrendsBuy This Stock SMA vs. ABT, ISRG, BSX, SYK, MDT, BDX, EW, IDXX, RMD, and DXCMShould you be buying Symmetry Medical stock or one of its competitors? The main competitors of Symmetry Medical include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), and DexCom (DXCM). These companies are all part of the "health care equipment" industry. Symmetry Medical vs. Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom Abbott Laboratories (NYSE:ABT) and Symmetry Medical (NYSE:SMA) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and community ranking. Do analysts recommend ABT or SMA? Abbott Laboratories currently has a consensus target price of $137.94, suggesting a potential upside of 6.32%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, equities analysts plainly believe Abbott Laboratories is more favorable than Symmetry Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abbott Laboratories 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 2.84Symmetry Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to ABT or SMA? In the previous week, Abbott Laboratories had 76 more articles in the media than Symmetry Medical. MarketBeat recorded 79 mentions for Abbott Laboratories and 3 mentions for Symmetry Medical. Abbott Laboratories' average media sentiment score of 1.20 beat Symmetry Medical's score of 0.00 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 43 Very Positive mention(s) 6 Positive mention(s) 20 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Positive Symmetry Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor ABT or SMA? Abbott Laboratories received 823 more outperform votes than Symmetry Medical when rated by MarketBeat users. However, 80.92% of users gave Symmetry Medical an outperform vote while only 69.97% of users gave Abbott Laboratories an outperform vote. CompanyUnderperformOutperformAbbott LaboratoriesOutperform Votes94669.97% Underperform Votes40630.03% Symmetry MedicalOutperform Votes12380.92% Underperform Votes2919.08% Do institutionals & insiders have more ownership in ABT or SMA? 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is ABT or SMA more profitable? Abbott Laboratories has a net margin of 31.95% compared to Symmetry Medical's net margin of 0.00%. Abbott Laboratories' return on equity of 20.74% beat Symmetry Medical's return on equity.Company Net Margins Return on Equity Return on Assets Abbott Laboratories31.95% 20.74% 11.19% Symmetry Medical N/A N/A N/A Which has higher valuation and earnings, ABT or SMA? Abbott Laboratories has higher revenue and earnings than Symmetry Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbbott Laboratories$41.95B5.36$13.40B$7.6516.96Symmetry MedicalN/AN/AN/AN/AN/A SummaryAbbott Laboratories beats Symmetry Medical on 13 of the 14 factors compared between the two stocks. Remove Ads Get Symmetry Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for SMA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMA vs. The Competition Export to ExcelMetricSymmetry Medical Industry SectorNYSE ExchangeMarket CapN/A$2.58B$2.34B$18.33BDividend YieldN/A13.18%13.20%4.23%P/E RatioN/A11.2710.9830.99Price / SalesN/A2,042,832.103,353,510.3725.39Price / CashN/A16.0854.9917.53Price / BookN/A3.103.274.26Net IncomeN/A$48.04M-$311.34M$1.02B Symmetry Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMASymmetry MedicalN/A$32.56-0.6%N/AN/A$0.00N/A0.00N/ANews CoverageHigh Trading VolumeABTAbbott Laboratories4.8689 of 5 stars$127.13+2.6%$137.94+8.5%+15.8%$220.48B$41.95B16.62115,000Earnings ReportOptions VolumeNews CoveragePositive NewsGap UpISRGIntuitive Surgical4.7939 of 5 stars$522.95+14.3%$611.86+17.0%+29.4%$186.26B$8.35B81.5812,100Upcoming EarningsPositive NewsHigh Trading VolumeBSXBoston Scientific4.4284 of 5 stars$96.86+6.9%$108.91+12.4%+39.7%$143.26B$16.75B77.4945,000Upcoming EarningsAnalyst UpgradePositive NewsHigh Trading VolumeSYKStryker4.6755 of 5 stars$363.44+7.7%$421.90+16.1%+2.3%$138.72B$22.60B46.8451,000Positive NewsHigh Trading VolumeMDTMedtronic4.667 of 5 stars$85.42+4.3%$96.07+12.5%+2.5%$109.55B$33.20B25.9695,000Short Interest ↓Positive NewsBDXBecton, Dickinson and Company4.8296 of 5 stars$209.57+4.4%$275.71+31.6%-13.9%$60.17B$20.64B34.8177,000Short Interest ↑Analyst RevisionEWEdwards Lifesciences4.514 of 5 stars$69.86+4.2%$79.95+14.4%-20.8%$41.07B$5.44B10.0217,300Insider TradeNews CoveragePositive NewsIDXXIDEXX Laboratories4.7984 of 5 stars$397.10+10.0%$533.75+34.4%-17.8%$32.18B$3.90B37.2210,800Analyst ForecastPositive NewsGap DownHigh Trading VolumeRMDResMed4.4042 of 5 stars$216.70+5.9%$249.73+15.2%+15.6%$31.83B$4.93B25.588,160Upcoming EarningsAnalyst UpgradeAnalyst RevisionPositive NewsDXCMDexCom4.903 of 5 stars$66.84+10.1%$99.82+49.3%-48.6%$26.21B$4.03B46.747,600Positive News Remove Ads Related Companies and Tools Related Companies Abbott Laboratories Alternatives Intuitive Surgical Alternatives Boston Scientific Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SMA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFBI Warns: Wave Of Retiree Cyber Hacks Coming In 2025Try to think back to the fall of 2008… The pandemic accelerated America's descent into a “no-cash society” ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Symmetry Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Symmetry Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SMA Stock Free SMA Stock Alerts